A lot of patients with type 2 diabetes confuse basal insulin with rapid acting insulin

According to the result of 'Blood glucose control in patients with type 2 diabetes and Survey of whether the patients know the features of insulin pen' which Novo Nordisk Pharmaceutical asked a research company Ipsos to do in the last end of 2013, it turned out that 26% of all patients confuse basal insulin with rapid acting insulin.

This survey was conducted based on 300 patients with type 2 ...